• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高压氧治疗肛周克罗恩病

Hyperbaric oxygen for perianal Crohn's disease.

作者信息

Lavy A, Weisz G, Adir Y, Ramon Y, Melamed Y, Eidelman S

机构信息

Department of Gastroenterology, Rambam Medical Center, Haifa, Israel.

出版信息

J Clin Gastroenterol. 1994 Oct;19(3):202-5. doi: 10.1097/00004836-199410000-00006.

DOI:10.1097/00004836-199410000-00006
PMID:7806829
Abstract

Perianal involvement in Crohn's disease is common (< or = 50%), distressing, and frequently refractory to treatment. Clinical features include painful induration and stenosis, discharging fistulas, and fissures. The pathogenesis of these lesions is unclear, but local ischemia and secondary anaerobic infection may play a role. Following three sporadic reports of successful treatment with hyperbaric oxygen (HBO), we undertook a trial of this method in 10 patients with refractory perianal disease. These patients' perianal Crohn's disease had not responded to treatment that included local medications, salicylates, corticosteroids, metronidazole, or 6-mercaptopurine were treated. Treatment was administered in a hyperbaric chamber at a pressure of 2.5 atm absolute. Each session lasted 90 min, and each course consisted of 20 daily sessions. Complete healing occurred in 5 patients after one to two courses. In an additional 2, after three courses, 1 patient improved but did not heal, and 2 did not improve. No adverse effects were noted by any of the 10 patients. Follow-up of 18 months did not reveal any recurrence. These preliminary results confirm that HBO therapy is a safe and efficient therapeutic option for perianal Crohn's disease.

摘要

克罗恩病累及肛周很常见(≤50%),令人苦恼,且常常对治疗难治。临床特征包括疼痛性硬结和狭窄、有排液的瘘管及肛裂。这些病变的发病机制尚不清楚,但局部缺血和继发性厌氧菌感染可能起作用。在有3篇关于高压氧(HBO)成功治疗的散在报道后,我们对10例难治性肛周疾病患者进行了该方法的试验。这些患者的肛周克罗恩病对包括局部用药、水杨酸盐、皮质类固醇、甲硝唑或6-巯基嘌呤在内的治疗均无反应。治疗在高压舱内以绝对压力2.5个大气压进行。每次治疗持续90分钟,每个疗程包括每日20次治疗。1至2个疗程后5例患者完全愈合。另外2例患者,3个疗程后,1例改善但未愈合,2例无改善。10例患者均未观察到不良反应。18个月的随访未发现任何复发。这些初步结果证实,HBO治疗是肛周克罗恩病一种安全有效的治疗选择。

相似文献

1
Hyperbaric oxygen for perianal Crohn's disease.高压氧治疗肛周克罗恩病
J Clin Gastroenterol. 1994 Oct;19(3):202-5. doi: 10.1097/00004836-199410000-00006.
2
Adjunctive Hyperbaric Oxygen Therapy promotes successful healing in patients with refractory Crohn's disease.辅助性高压氧疗法可促进难治性克罗恩病患者的伤口顺利愈合。
Acta Cir Bras. 2016;31 Suppl 1:19-23. doi: 10.1590/S0102-86502016001300005.
3
Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease: Results of the HOT-TOPIC trial after 1-year follow-up.高压氧治疗对 20 例克罗恩病患者肛旁瘘的疗效:1 年随访的 HOT-TOPIC 试验结果。
United European Gastroenterol J. 2022 Mar;10(2):160-168. doi: 10.1002/ueg2.12189. Epub 2022 Feb 10.
4
Hyperbaric oxygenation in severe perineal Crohn's disease.重度会阴克罗恩病的高压氧治疗
Dis Colon Rectum. 1995 Jun;38(6):609-14. doi: 10.1007/BF02054120.
5
Perianal Crohn's disease.肛周克罗恩病
Neth J Med. 1994 Aug;45(2):72-5.
6
Hyperbaric oxygen therapy for the treatment of rectovaginal fistulas in patients with Crohn's disease: results of the HOT-REVA pilot study.高压氧治疗克罗恩病患者直肠阴道瘘的疗效:HOT-REVA 初步研究结果。
BJS Open. 2021 May 7;5(3). doi: 10.1093/bjsopen/zrab042.
7
[Hyperbaric oxygen in the treatment of perineal Crohn's disease era of infliximab: a renewal interest?].[在英夫利昔单抗时代高压氧治疗会阴克罗恩病:重新受到关注?]
Tunis Med. 2012 Jun;90(6):427-30.
8
Hyperbaric oxygen therapy for the treatment of perianal fistulas in 20 patients with Crohn's disease.高压氧治疗 20 例克罗恩病肛周瘘患者。
Aliment Pharmacol Ther. 2021 Mar;53(5):587-597. doi: 10.1111/apt.16228. Epub 2020 Dec 16.
9
Six patients whose perianal and ileocolic Crohn's disease improved in the Dead Sea environment.6名肛周和回结肠克罗恩病患者在死海环境中病情有所改善。
J Clin Gastroenterol. 1995 Oct;21(3):217-9. doi: 10.1097/00004836-199510000-00010.
10
Editorial: is hyperbaric oxygen a therapeutic opportunity for refractory perianal Crohn's disease?社论:高压氧是难治性肛周克罗恩病的治疗契机吗?
Aliment Pharmacol Ther. 2021 Mar;53(5):667-668. doi: 10.1111/apt.16253.

引用本文的文献

1
Hyperbaric Oxygen Therapy in the Treatment of Crohn's Disease.高压氧疗法治疗克罗恩病
Healthcare (Basel). 2025 Jan 11;13(2):128. doi: 10.3390/healthcare13020128.
2
Hyperbaric Oxygen Therapy in Systemic Inflammatory Response Syndrome.全身炎症反应综合征中的高压氧治疗
Vet Sci. 2022 Jan 18;9(2):33. doi: 10.3390/vetsci9020033.
3
Managing complex perianal disease after anti-TNF failure: Where to go next?抗TNF治疗失败后复杂肛周疾病的管理:下一步何去何从?
Curr Res Pharmacol Drug Discov. 2022 Jan 13;3:100081. doi: 10.1016/j.crphar.2022.100081. eCollection 2022.
4
The role of hyperbaric oxygen therapy in inflammatory bowel disease: a narrative review.高压氧疗法在炎症性肠病中的作用:一篇叙述性综述。
Med Gas Res. 2021 Apr-Jun;11(2):66-71. doi: 10.4103/2045-9912.311497.
5
Perianal Fistulas in Patients With Crohn's Disease, Part 1: Current Medical Management.克罗恩病患者的肛周瘘管,第1部分:当前的药物治疗
Gastroenterol Hepatol (N Y). 2018 Aug;14(8):470-481.
6
Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy.肛周瘘管性克罗恩病:发病机制、诊断与治疗。
Nat Rev Gastroenterol Hepatol. 2017 Nov;14(11):652-664. doi: 10.1038/nrgastro.2017.104. Epub 2017 Aug 9.
7
Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn's disease.英夫利昔单抗、抗分枝杆菌治疗及高压氧疗法联合用于治疗耐药性瘘管型克罗恩病。
Future Sci OA. 2015 Sep 28;1(4):FSO77. doi: 10.4155/fso.15.77. eCollection 2015 Nov.
8
Hyperbaric oxygen therapy ameliorates TNBS-induced acute distal colitis in rats.高压氧疗法可改善三硝基苯磺酸诱导的大鼠急性远端结肠炎。
Med Gas Res. 2015 Apr 16;5:6. doi: 10.1186/s13618-015-0026-2. eCollection 2015.
9
Hyperbaric oxygen treatment in autism spectrum disorders.自闭症谱系障碍的高压氧治疗
Med Gas Res. 2012 Jun 15;2(1):16. doi: 10.1186/2045-9912-2-16.
10
Hyperbaric oxygen treatment for inflammatory bowel disease: a systematic review and analysis.高压氧治疗炎症性肠病:一项系统评价与分析
Med Gas Res. 2012 Mar 15;2(1):6. doi: 10.1186/2045-9912-2-6.